A new tool bowel ultrasound is emerging as a non-invasive tool for monitoring disease activity in inflammatory bowel disease patients. This is due to its low cost, excellent safety profile, and availability. Also as Bowel ultrasound now in Egypt, it is only present at Dr Amr Elgazzar specialized center.
First, bowel ultrasound has a good accuracy in the diagnosis of Crohn’s disease.
Second, it is used in the assessment of disease activity, extent, and evaluating disease-related complications. As strictures, fistulae, and abscesses.
Third, bowel ultrasound can also be used to assess response to treatment. As changes in ultrasonographic parameters are observed as early as 4 weeks. And also after treatment initiation which persist during short- and long-term follow-up.
Additionally, Crohn’s disease patients with no ultrasound improvement seem to be at a higher risk of therapy intensification. As they need steroids, hospitalization, or even surgery.
Similarly to Crohn’s disease, bowel ultrasound has a good performance in the diagnosis, activity, and disease extent assessment in ulcerative colitis patients. In fact, in patients with severe acute colitis, higher bowel wall thickness at admission is associated with the need for salvage therapy. And the absence of a significant decrease in this parameter may predict the need for colectomy.
Finally, screening of inflammatory bowel disease.
IUS (intestinal ultrasound) has been used as a screening tool in patients with gastrointestinal (GI) symptoms. But without the severe signs of the disease (such as weight loss, anaemia, or elevated FCal).
Also shows a good accuracy to distinguish IBD from irritable bowel syndrome patients in primary care settings.
Doctorate in Gastrointestinal Diseases, Liver Diseases and Endoscopy. Dr. Member of the American and European Societies of Gastrointestinal Endoscopy Ultrasound examination Consultant of the colon and small intestine (intestinal ultrasound)
Made by ELSHAER Advertising | All rights reserved Dr-Amr Elgazzar